window.pageData = {"stock":{"_id":3000000024599,"name":"兴业医疗创新混合型发起式证券投资基金","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","status":"normal","stockCode":"024599","tickerId":24599,"shortName":"兴业医疗创新混合发起式C","currency":"CNY","exchange":"jj","masterFundFlag":null,"indexFundFlag":null,"activeFundFlag":null,"etfFundFlag":null,"lofFundFlag":null,"pensionTargetFlag":null,"feederFundFlag":null,"classificationFlag":null,"closedEnd":null,"inceptionDate":"2025-06-29T16:00:00.000Z","pinyin":"xyylcxhhxfqszqtzjj","fundCollectionId":4000050810000,"fundCollection":{"exchange":"jjgs","stockType":"fund_collection","stockCode":"50810000","tickerId":50810000,"name":"兴业基金管理有限公司"},"managers":[{"name":"代鹏举","stockType":"fund_manager","stockCode":"j101019786","exchange":"fm","tickerId":41610247030}],"hotMetrics":{"fss":{"stockId":3000000024599,"type":"fss","last_data_date":"2025-12-30T16:00:00.000Z","f_ins_h_s_r":0,"f_ind_h_s_r":1,"f_h_a":34},"fpr":{"stockId":3000000024599,"type":"fpr","f_cagr_p_r_fs_ssc":9174,"f_cagr_p_r_fs_ssrp":0.9950942984846833,"f_p_r_m1_ssc":9231,"f_p_r_m1_ssrp":0.9729144095341279,"f_p_r_m3_ssc":9128,"f_p_r_m3_ssrp":0.8742193491837406,"f_p_r_m6_ssc":8818,"f_p_r_m6_ssrp":0.956220936826585,"f_p_r_fys_ssc":8989,"f_p_r_fys_ssrp":0.9196706720071206},"fp":{"stockId":3000000024599,"type":"fp","last_data_date":"2026-05-18T16:00:00.000Z","f_p_r_m1":-0.0811575282854653,"f_p_r_m3":-0.06931129476583997,"f_cagr_p_r_fs":-0.15539999999999998,"f_p_r_m6":-0.10624338624338614,"f_p_r_fys":-0.05589090096132321},"ff":{"stockId":3000000024599,"type":"ff","f_fr_d":"2025-12-30T16:00:00.000Z","f_m_fr":0.012,"f_c_fr":0.002,"f_mac_fr":0.014},"f_nlacan":{"stockId":3000000024599,"type":"f_nlacan","f_nv_d":"2026-05-18T16:00:00.000Z","f_nv":0.8446,"f_nv_cr":0.005236848369435831},"f_as":{"stockId":3000000024599,"type":"f_as","f_tas":46173.254400000005,"f_tas_d":"2026-03-30T16:00:00.000Z"}},"masterSlaveFunds":[{"_id":3000000024598,"__csrcFundId":15324,"stockCode":"024598","masterFundShortName":"兴业医疗创新混合发起式","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","tickerId":24598,"currency":"CNY","masterFundFlag":1,"status":"normal","exchange":"jj","shortName":"兴业医疗创新混合发起式(024598)","lastUpdated":"2026-05-01T04:20:05.177Z","name":"兴业医疗创新混合型发起式证券投资基金","pinyin":"xyylcxhhxfqszqtzjj","fundCollectionId":4000050810000,"setUpAssetScale":10001994.14,"setUpDate":"2025-06-29T16:00:00.000Z","setUpShares":10001994.14,"inceptionDate":"2025-06-29T16:00:00.000Z","followedNum":4}],"shareholdings":[{"date":"2026-03-30T16:00:00.000Z","declarationDate":"2026-04-21T16:00:00.000Z","fundId":3000000024598,"stockId":600276,"holdings":11300,"marketCap":623986,"netValueRatio":0.0714,"quarterlyChange":-0.07302333389289883,"stock":{"stockCode":"600276","exchange":"sh","stockType":"company","tickerId":600276,"name":"恒瑞医药"}},{"date":"2026-03-30T16:00:00.000Z","declarationDate":"2026-04-21T16:00:00.000Z","fundId":3000000024598,"stockId":2020,"holdings":30000,"marketCap":471600,"netValueRatio":0.054,"quarterlyChange":-0.17175974710221265,"stock":{"stockCode":"002020","exchange":"sz","stockType":"company","tickerId":2020,"name":"京新药业"}},{"date":"2026-03-30T16:00:00.000Z","declarationDate":"2026-04-21T16:00:00.000Z","fundId":3000000024598,"stockId":1000000000001530,"holdings":23000,"marketCap":459769,"netValueRatio":0.0526,"quarterlyChange":-0.06368899917286963,"stock":{"stockCode":"01530","exchange":"hk","stockType":"company","tickerId":1530,"name":"三生制药"}},{"date":"2026-03-30T16:00:00.000Z","declarationDate":"2026-04-21T16:00:00.000Z","fundId":3000000024598,"stockId":1000000000006990,"holdings":1000,"marketCap":406157,"netValueRatio":0.0465,"quarterlyChange":0.17287098419173907,"stock":{"exchange":"hk","stockType":"company","stockCode":"06990","tickerId":6990,"name":"科伦博泰生物"}},{"date":"2026-03-30T16:00:00.000Z","declarationDate":"2026-04-21T16:00:00.000Z","fundId":3000000024598,"stockId":603259,"holdings":4000,"marketCap":392400,"netValueRatio":0.0449,"quarterlyChange":0.08230361871138547,"stock":{"stockCode":"603259","exchange":"sh","stockType":"company","tickerId":603259,"name":"药明康德"}},{"date":"2026-03-30T16:00:00.000Z","declarationDate":"2026-04-21T16:00:00.000Z","fundId":3000000024598,"stockId":2422,"holdings":11300,"marketCap":391997,"netValueRatio":0.0448,"quarterlyChange":0.1819420783645651,"stock":{"stockCode":"002422","exchange":"sz","stockType":"company","tickerId":2422,"name":"科伦药业"}},{"date":"2026-03-30T16:00:00.000Z","declarationDate":"2026-04-21T16:00:00.000Z","fundId":3000000024598,"stockId":1000000000001801,"holdings":5000,"marketCap":374812,"netValueRatio":0.0429,"quarterlyChange":0.11344262295081897,"stock":{"stockCode":"01801","exchange":"hk","stockType":"company","tickerId":1801,"name":"信达生物"}},{"date":"2026-03-30T16:00:00.000Z","declarationDate":"2026-04-21T16:00:00.000Z","fundId":3000000024598,"stockId":688513,"holdings":5054,"marketCap":325427,"netValueRatio":0.0372,"quarterlyChange":0.046141348497156676,"stock":{"stockCode":"688513","tickerId":688513,"exchange":"sh","stockType":"company","name":"苑东生物"}},{"date":"2026-03-30T16:00:00.000Z","declarationDate":"2026-04-21T16:00:00.000Z","fundId":3000000024598,"stockId":688331,"holdings":2500,"marketCap":321925,"netValueRatio":0.0368,"quarterlyChange":0.6553541586322154,"stock":{"name":"荣昌生物","exchange":"sh","stockType":"company","stockCode":"688331","tickerId":688331}},{"date":"2026-03-30T16:00:00.000Z","declarationDate":"2026-04-21T16:00:00.000Z","fundId":3000000024598,"stockId":688221,"holdings":15000,"marketCap":284250,"netValueRatio":0.0325,"quarterlyChange":0.049861495844875314,"stock":{"stockCode":"688221","tickerId":688221,"exchange":"sh","stockType":"company","name":"前沿生物"}}],"bondHoldings":[{"_id":"69e8fbf21398d79843004140","date":"2026-03-30T16:00:00.000Z","declarationDate":"2026-04-21T16:00:00.000Z","fundId":3000000024598,"stockCode":"019792","stockName":"25国债19","holdings":5000,"marketCap":503775,"netValueRatio":0.0576,"lastUpdated":"2026-04-22T16:48:50.991Z"}]},"list":[{"_id":"69e8eca21398d79843fea03c","date":"2026-03-30T16:00:00.000Z","declarationDate":"2026-04-21T16:00:00.000Z","stockId":3000000024598,"sao":"一季度主要配置具有产业趋势的创新药，以及景气度改善的CXO，但因外部不确定性较大，布局以偏低波动的大市值公司为主。展望二季度，国家将生物医药列为“新兴支柱产业”之一，全球投融资市场回暖，中国创新药对外授权交易额一季度已突破600亿美元，为去年一半水平，创新药产业趋势仍在加强；另一方面，医药板块已经回调到具备一定性价比的位置，伴随二季度产业学术会议催化，预计创新药将会有一波机会。同时，CXO领域依托于多肽、减重药等大单品需求，结构性机会变多，创新器械探索新业务与出海逻辑，或有第二增长曲线和业绩双驱动。二季度将积极提高仓位，布局高景气、有催化、有新逻辑、业绩有支撑、有高赔率的结构性机会。","lastUpdated":"2026-04-22T15:43:30.842Z","fund":{"_id":3000000024598,"__csrcFundId":15324,"stockCode":"024598","masterFundShortName":"兴业医疗创新混合发起式","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","tickerId":24598,"currency":"CNY","masterFundFlag":1,"status":"normal","exchange":"jj","shortName":"兴业医疗创新混合发起式(024598)","lastUpdated":"2026-05-01T04:20:05.177Z","name":"兴业医疗创新混合型发起式证券投资基金","pinyin":"xyylcxhhxfqszqtzjj","fundCollectionId":4000050810000,"setUpAssetScale":10001994.14,"setUpDate":"2025-06-29T16:00:00.000Z","setUpShares":10001994.14,"inceptionDate":"2025-06-29T16:00:00.000Z","followedNum":4,"managers":[{"stockCode":"j101019786","stockType":"fund_manager","exchange":"fm","tickerId":41610247030,"name":"代鹏举"}]},"announcement":{"linkText":"兴业医疗创新混合型发起式证券投资基金2026年第一季度报告","linkUrl":"http://eid.csrc.gov.cn/fund/disclose/instance_show_pdf_id.do?instanceid=1477330","linkType":"PDF","source":"csrc_pdf"}},{"_id":"69c7705669b11a867413e1d3","date":"2025-12-30T16:00:00.000Z","declarationDate":"2026-03-27T16:00:00.000Z","stockId":3000000024598,"sao":"2025年医药板块从周期底部向上拐头，总量层面的新逻辑主要来自创新药出海，内需复苏受限于经济总体水平和医保政策调整等仍有一定程度压制，伴随市场风偏起来，基金组合运行策略从上一年的哑铃配置，逐步偏向更多进攻型资产，创新药、医疗AI、脑机接口等成为主要的医药科技主题，随后市场挑选出具有强基本面支撑的创新药，同时凭借肌肉记忆和弱复苏数据带动CXO共同演绎，演绎到年中，随着头部公司BD又延续一波鱼尾行情，后续震荡、回调，部分资金切入非药，但非药基本面平淡承压，仍在去库周期U底且没有预期中的内需复苏，这期间医药没有大行情，流感主题等有一波小演绎，基本属于短暂小浪花，后续处于等待阶段，需要回调进入合适的赔率。本基金坚持以“基本面为锚，创新为矛”的投资策略，重点配置具备全球竞争力的创新药企、转型中的传统药企龙头以及具有景气细分赛道的CXO标的。","lastUpdated":"2026-03-28T06:08:22.267Z","mo":"展望2026年，医药行情预期表现平稳，保持一个合理的收益率预期，内部结构性分化。组合配置上，主要有三个方向：第一，创新药仍为重要且中长期趋势的产业逻辑，更多聚焦已经出海并开始兑现的公司，以及真正具有FIC或者全球前三BIC的公司；根据市场不同的风险偏好，动态调整纯创新药公司和转型创新药且有存量业务支撑的公司，兼顾生物技术领域细分赛道共振，包括小核酸、分子胶、新一代ADC/XDC、细胞治疗等。第二，阶段性配置不同比例医疗科技主题，优化CXO与医疗器械持仓结构，聚焦具备全球化服务能力、成本优势突出的头部企业，同时关注AI赋能药物发现、细胞与基因治疗等前沿技术平台，器械领域关注手术机器人和有出海机会的标的，同时关注AI医疗和脑机接口的阶段性投资机会。整体上，我们将维持动态仓位操作，通过“核心+卫星”策略构建进攻型产品组合，力争在2026年医药板块中创造超额收益。","fund":{"_id":3000000024598,"__csrcFundId":15324,"stockCode":"024598","masterFundShortName":"兴业医疗创新混合发起式","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","tickerId":24598,"currency":"CNY","masterFundFlag":1,"status":"normal","exchange":"jj","shortName":"兴业医疗创新混合发起式(024598)","lastUpdated":"2026-05-01T04:20:05.177Z","name":"兴业医疗创新混合型发起式证券投资基金","pinyin":"xyylcxhhxfqszqtzjj","fundCollectionId":4000050810000,"setUpAssetScale":10001994.14,"setUpDate":"2025-06-29T16:00:00.000Z","setUpShares":10001994.14,"inceptionDate":"2025-06-29T16:00:00.000Z","followedNum":4,"managers":[{"stockCode":"j101019786","stockType":"fund_manager","exchange":"fm","tickerId":41610247030,"name":"代鹏举"}]},"announcement":{"linkText":"兴业医疗创新混合型发起式证券投资基金2025年年度报告","linkUrl":"http://eid.csrc.gov.cn/fund/disclose/instance_show_pdf_id.do?instanceid=1450142","linkType":"PDF","source":"csrc_pdf"}},{"_id":"69aed4027fea5b3eb0543cbb","date":"2025-09-29T16:00:00.000Z","declarationDate":"2025-10-27T16:00:00.000Z","stockId":3000000024598,"sao":"三季度本基金逐步建仓，主要集中在创新药板块，部分仓位配置在CXO板块。创新药有较强的产业趋势，产业逻辑没有走完，短期经历前三个季度的快速上涨，现阶段进入高位震荡区间，在短期涨幅较大的前提下，后续标的选择上偏保守，更多偏向下有底的仿创转型标的，对于头部贝塔公司尤其是涨幅巨大的公司做了适当的减仓。预计未来一个季度保持足够的耐心，选择一些位置较低的标的防守，等调整到位之后再进攻。细分板块配置上，维持看好具有强产业趋势的创新药及其产业链。","lastUpdated":"2026-03-09T14:06:58.768Z","fund":{"_id":3000000024598,"__csrcFundId":15324,"stockCode":"024598","masterFundShortName":"兴业医疗创新混合发起式","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","tickerId":24598,"currency":"CNY","masterFundFlag":1,"status":"normal","exchange":"jj","shortName":"兴业医疗创新混合发起式(024598)","lastUpdated":"2026-05-01T04:20:05.177Z","name":"兴业医疗创新混合型发起式证券投资基金","pinyin":"xyylcxhhxfqszqtzjj","fundCollectionId":4000050810000,"setUpAssetScale":10001994.14,"setUpDate":"2025-06-29T16:00:00.000Z","setUpShares":10001994.14,"inceptionDate":"2025-06-29T16:00:00.000Z","followedNum":4,"managers":[{"stockCode":"j101019786","stockType":"fund_manager","exchange":"fm","tickerId":41610247030,"name":"代鹏举"}]},"announcement":{"linkText":"兴业医疗创新混合型发起式证券投资基金2025年第三季度报告","linkUrl":"http://eid.csrc.gov.cn/fund/disclose/instance_show_pdf_id.do?instanceid=1374690","linkType":"PDF","source":"csrc_pdf"}}]}